Product image of Yervoy (Ipilimumab) supplied by GNH India

Yervoy

Active Ingredient:
Ipilimumab
Origin:
EU

Yervoy (Ipilimumab)

Ipilimumab (Yervoy) is an intravenous immunotherapy used to treat certain cancers by helping the immune system recognize and attack tumor cells. It is prescribed under medical supervision for advanced melanoma and other malignancies. This overview covers key details for informational purposes only.

Manufacturer / TM Owner

Bristol-Myers Squibb Pharma Eeig

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Ipilimumab (Yervoy) is primarily used to treat advanced melanoma, a serious form of skin cancer, by enhancing the body's immune response against cancer cells. It may also be prescribed for other types of cancer as determined by a healthcare provider. This medication is administered intravenously and is designed to work with the immune system to slow or stop cancer progression.

Side Effects

  • As an immunotherapy, ipilimumab (Yervoy) works by blocking a protein that prevents immune cells from attacking cancer cells. Patients may experience immune-related effects as the body's immune system becomes more active. These effects can vary widely and should be monitored by a healthcare professional throughout treatment.

Precautions & Warnings

  • Ipilimumab (Yervoy) should only be handled and administered by qualified healthcare providers due to its specialized nature. Patients receiving this medication require close monitoring for immune-related side effects, which can affect multiple organs. It is important to discuss full medical history with a doctor before starting treatment.

Avoid Interactions

  • Ipilimumab (Yervoy) may interact with other medications that affect the immune system, such as corticosteroids or immunosuppressants. Combining it with certain therapies could alter its effectiveness or increase the risk of side effects. Always inform your healthcare provider about all medications and supplements being taken.

Frequently Asked Questions

Ipilimumab (Yervoy) is used to treat advanced melanoma and may be prescribed for other cancers as determined by a doctor.

Ipilimumab is given as an intravenous infusion in a clinical setting under medical supervision.

Common effects may include fatigue, skin reactions, and immune-related symptoms, which should be reported to a healthcare provider.

It may interact with other drugs; always consult a healthcare provider before combining treatments.

No, ipilimumab requires a prescription and must be administered by a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ipilimumab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT